Telehealth company Hims & Hers said it would no longer sell a copycat of a popular weight-loss pill following regulatory scrutiny from US officials.
The brand’s cheaper version of Novo Nordisk’s Wegovy pill was potentially illegal, federal authorities had warned: Hims & Hers has marketed itself as a low-cost way for Americans to get access to in-demand medications using “compounded,” near-identical versions that aren’t reviewed by federal drug regulators.
The episode reflects the market frenzy stemming from the global boom in weight-loss medications in recent years, but Hims & Hers has wider ambitions, like “personalized” testosterone medications.
It evokes “concierge treatments enjoyed by the rich,” The Atlantic wrote.